HORIZANT - 0173-0832-13 - (gabapentin enacarbil)

Alphabetical Index


Drug Information of HORIZANT

Product NDC: 0173-0832
Proprietary Name: HORIZANT
Non Proprietary Name: gabapentin enacarbil
Active Ingredient(s): 300    mg/1 & nbsp;   gabapentin enacarbil
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of HORIZANT

Product NDC: 0173-0832
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022399
Marketing Category: NDA
Start Marketing Date: 20111215

Package Information of HORIZANT

Package NDC: 0173-0832-13
Package Description: 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0173-0832-13)

NDC Information of HORIZANT

NDC Code 0173-0832-13
Proprietary Name HORIZANT
Package Description 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0173-0832-13)
Product NDC 0173-0832
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name gabapentin enacarbil
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20111215
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name GABAPENTIN ENACARBIL
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]

Complete Information of HORIZANT


General Information